Zhang, J., Sun, R., Lyu, Y., Liu, C., Liu, Y., Feng, Y., . . . Mao, Y. (2024). Proteomic profiling of gliomas unveils immune and metabolism-driven subtypes with implications for anti-nucleotide metabolism therapy. Nature Communications, 15(1), . https://doi.org/10.1038/s41467-024-54352-5
Chicago-referens (17:e uppl.)Zhang, Jinsen, et al. "Proteomic Profiling of Gliomas Unveils Immune and Metabolism-driven Subtypes with Implications for Anti-nucleotide Metabolism Therapy." Nature Communications 15, no. 1 (2024). https://doi.org/10.1038/s41467-024-54352-5.
MLA-referens (9:e uppl.)Zhang, Jinsen, et al. "Proteomic Profiling of Gliomas Unveils Immune and Metabolism-driven Subtypes with Implications for Anti-nucleotide Metabolism Therapy." Nature Communications, vol. 15, no. 1, 2024, https://doi.org/10.1038/s41467-024-54352-5.
